The march of digitisation and technology convergence in health is advancing at an astounding rate.

It covers everything from sophisticated AI disease detection to the time consuming but important task of plate reading in pathology and that is where LBT innovations [ASX:LBT] comes in.

Pathology labs around the world have to manually check tens of thousands of Agar ‘plates’, used to grow bacteria and other microorganisms, every day.

But LBT Innovations [ASX:LBT] has developed a solution to the manual handling based around AI and the company is now entering its global expansion phase.